A new eBook is now available to download from Bio-Techne entitled ‘Advances in the analysis of next-generation biotherapeutics’. Discover how to accelerate ADC development with clearer, faster characterisation of charge heterogeneity and size/purity. This eBook explains when to apply advanced icIEF and CE-SDS methods for ADCs and other novel biotherapeutics… Read More
Discover how to accelerate ADC development with clearer, faster characterisation of charge heterogeneity and size/purity. This eBook explains when to apply advanced icIEF and CE-SDS methods for ADCs and other novel biotherapeutics to accelerate development timelines. Learn: icIEF vs IEX for ADC charge profiles Protecting unstable ADCs with on-board mixing… Read More
This is the latest episode of the free DDW narrated podcast, titled “How is precision medicine making its mark in drug discovery?”, which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “Accelerating biotherapy and personalised medicine with long DNA”… Read More
Recent research is shedding light on the crucial role of B cells in the fight against cancer, opening exciting new avenues for therapeutic development, according to Stefano Gullà, Chief Scientific Officer at Kling Biotherapeutics. Cancer immunotherapies have been raising the bar for standard of care in oncology for more than… Read More
Tech transfer is all about transferring technology, knowledge, and expertise from one phase of development to another, or from one facility to another, to ensure the successful replication and scaling up of biotherapeutic products. This involves several key activities such as knowledge and process transfer, process standardisation, quality and compliance,… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Join DDW and Thermo Fisher Scientific on 20 June, 11AM EDT/4PM BST, for an exclusive webinar, ‘Advancing biotherapy manufacturing: innovative strategies for residual DNA and viral titre quantitation using dPCR’. This free event will feature insight from Thermo Fisher Scientific’s Jonas Buege, Senior… Read More
Leveraging digital PCR-based assays for the quantitation of residual host cell DNA or viral titres within a biotherapeutic manufacturing workflow offers significant value in ensuring product quality and safety. Digital PCR, or dPCR, is a highly sensitive and precise technique that enables the absolute quantification of nucleic acid targets. In… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will be presented by Ron… Read More
Join DDW for this free event, ‘Higher throughput bioanalytical methods accelerate the development and evaluation of advanced biotherapeutics’, which is supported by Revvity. It will take place on 2 May at 3pm BST, 10am EDT, 4pm CEST and will presented by Ron Morena,… Read More
Successful development of advanced biotherapeutics relies on extensive characterisation and tight quality control. Characterising binding properties of complex biomolecules is a critical step. Biophysical data combined with functional assays are needed to predict efficacy and potency, optimise drug delivery, assess critical quality attributes, and improve biologics drug design. Traditional approaches have… Read More
DDW is delighted to announce the final speaker on its SLAS2024 Ignite Theater track ‘Innovation & technology: from lab to patient’, co-sponsored by Integra Biosciences and Hamamatsu Corporation. Dipanwita Das On Monday 5 February at 11.30am, Dipanwita Das, CEO and Co-founder of Sorcero,… Read More
